Drug screening is a type of test carried out to determine an individual’s scope and degree of drug abuse. The global drug screening market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7% from 2017 to 2023. Drug testing is mandated imperative by many organizations and institutes to maintain an addiction free and sober workforce. Healthy and sober workforce helps maintain high productivity and a proper work environment. Special rules are issued by government regarding use of drug abuse in public places such as railway stations, airports etc. to ensure safety of local population. Use of performance enhancement drugs often termed as ‘doping’ is increasing problem in professional sports which is regulated by international sports organizations by establishing rules and prohibiting drugs.
Technological advancements in drug screening devices and upsurge in applications of these devices in market drives the drugs screening market. Moreover, increase in alcohol consumption and illicit use of prescribed drugs by ageing population, increase in government funding for drug testing programs augment market growth. However, the fact that drug testing is considered as a violation right in some countries, precision and accuracy issues regarding breath analyzers, ban on alcohol consumption in various countries restrain the market growth. The use of advanced technology in the drug testing devices and untapped emerging economies offer lucrative opportunities for the market players.
The global drug screening market is segmented based on equipment and services, sample type, end user, and geography. Based on equipment and services, the market is segmented into equipment, rapid testing devices, consumables and laboratory services. Equipment segment is further bifurcated by type into immunoassay analyzers, chromatography instruments and breath analyzers. Breath analyzer are further divided into fuel cell analyzers, semiconductor analyzers and other devices. Rapid testing devices are divided into oral fluid testing devices and urine testing devices. Consumables segment is further bifurcated into assay kits, calibrators and controls, samples collection cups and other materials such as gloves, cotton swabs, syringes and others.
Based on sample type, this market is bifurcated into urine, oral fluid/saliva, breath, hair and others (blood and sweat). Urine sample test is widely used as this sample can be collected without causing any pain to the patient and is one of the most convenient detection method. Thus, urine sample screening tests held a major share in this segment in the year 2015 and this trend is likely to continue over the forecast period. Hair sample is expected to grow at a remarkable CAGR and is the fastest growing segment in drug screening market.
Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the drug screening market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power, availability, and applications that favor the utilization of drug screening in this region. However, Asia-Pacific is expected to emerge as a lucrative area with significant growth potential, owing to the improvement in R&D facilities, available disposable income, and rapidly developing economic conditions.
KEY MARKET BENEFITS
KEY PLAYERS PROFILED
KEY MARKET SEGMENTS:
By Product & Service
By Sample Type
By End User
Other players in the value chain include (profiles not included in the report)
The Global Cetirizine Hydrochloride market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Cetirizine Hydrochloride market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses ...
November 2017 | $4660 |View Details>>
In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include UCB Pharma Pfizer J ...
November 2017 | $3360 |View Details>>
In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in ...
November 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research